KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Cash from Financing Activities (2016 - 2025)

HCA Healthcare (HCA) has disclosed Cash from Financing Activities for 16 consecutive years, with -$999.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 53.81% to -$999.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$8.6 billion, a 86.6% decrease, with the full-year FY2025 number at -$8.6 billion, down 86.6% from a year prior.
  • Cash from Financing Activities was -$999.0 million for Q4 2025 at HCA Healthcare, up from -$3.0 billion in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $425.0 million in Q1 2022 to a low of -$3.1 billion in Q2 2025.
  • A 5-year average of -$1.5 billion and a median of -$1.2 billion in 2021 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: surged 120.2% in 2022, then tumbled 2597.27% in 2025.
  • HCA Healthcare's Cash from Financing Activities stood at -$306.0 million in 2021, then plummeted by 500.65% to -$1.8 billion in 2022, then soared by 43.47% to -$1.0 billion in 2023, then crashed by 108.18% to -$2.2 billion in 2024, then surged by 53.81% to -$999.0 million in 2025.
  • Per Business Quant, the three most recent readings for HCA's Cash from Financing Activities are -$999.0 million (Q4 2025), -$3.0 billion (Q3 2025), and -$3.1 billion (Q2 2025).